The rationale for blending these two peptides stems from their non-overlapping receptor targets and complementary metabolic effects: Amylin Pathway (Cagrilintide): Targets amylin receptors in the brainstem Creates meal-specific satiety signals Slows gastric emptying through distinct mechanisms Reduces meal size and eating frequency Triple Agonist Pathway (Retatrutide): Activates GIP, GLP-1, and glucagon receptors Enhances insulin secretion and glucose metabolism Increases energy expenditure through glucagon effects Provides broader metabolic regulation When combined, these pathways could theoretically provide additive or synergistic effects on weight management and metabolic function
Alopecia is listed directly in section 6.1 (Clinical Trials) of the FDA label
The cream, with a pleasant lychee and berry fragrance and a mild warming effect, provides a smoother, firmer-looking skin and leaves it feeling softer after application
Exogenous MOTS-c is now in early-phase human trials
In adulthood, challenges around independent living, employment and relationships come to the fore
DOI: 10.1016/j.clnu.2023.06.027 Gualdiero, P., Ferrara, L., Ferrara, E., et al
